ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

PASG Passage Bio Inc

1,31
-0,03 (-2,24%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Passage Bio Inc PASG NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,03 -2,24% 1,31 23:16:11
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,34 1,30 1,38 1,31 1,34
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
22.4.202413:00GLOBEPassage Bio to Present at Chardan’s 8th Annual Genetic..
05.3.202413:00GLOBEPassage Bio Seeks Pennsylvania College Student Candidates..
04.3.202423:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
04.3.202422:09EDGAR2Form S-3 - Registration statement under Securities Act of..
04.3.202413:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
04.3.202413:02EDGAR2Form 8-K - Current report
04.3.202413:00GLOBEPassage Bio Reports Fourth Quarter and Full-Year 2023..
29.2.202422:06EDGAR2Form 8-K - Current report
27.2.202413:00GLOBEPassage Bio to Participate in Upcoming Investor Conferences
14.2.202415:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202401:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202401:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202422:05EDGAR2Form 8-K - Current report
03.1.202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.12.202322:15EDGAR2Form 8-K - Current report
20.12.202313:05EDGAR2Form 8-K - Current report
20.12.202313:00GLOBEPassage Bio Announces Promising Initial Data From Phase 1/2..
17.11.202322:30GLOBEPassage Bio Announces Inducement Grant Under Nasdaq Listing..
13.11.202313:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202313:00EDGAR2Form 8-K - Current report
13.11.202313:00GLOBEPassage Bio Reports Third Quarter 2023 Financial Results and..
30.10.202312:00GLOBEPassage Bio to Present at Guggenheim’s 5th Annual..
20.10.202322:30GLOBEPassage Bio Announces Inducement Grants Under Nasdaq Listing..
25.9.202313:00GLOBEPassage Bio to Present at Chardan’s 7th Annual Genetic..
01.9.202322:10EDGAR2Form 8-K - Current report
07.8.202313:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.8.202313:15GLOBEPassage Bio Reports Second Quarter 2023 Financial Results..
07.8.202313:15EDGAR2Form 8-K - Current report
07.8.202313:00GLOBEPassage Bio Announces Promising Interim Clinical Data from..
01.8.202322:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.8.202313:00GLOBEPassage Bio to Participate in Upcoming Investor Conferences
31.7.202323:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.7.202323:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
31.7.202313:00GLOBEPassage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of..
29.7.202300:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.7.202313:00EDGAR2Form 8-K - Current report
05.6.202313:00GLOBEPassage Bio to Present at Goldman Sachs 44th Annual Global..
11.5.202313:00GLOBEPassage Bio Reports First Quarter 2023 Financial Results and..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock